In the media
December 12, 2023

Navigating the micro and macro realms of biology through spatial omics and AI

Authors
No items found.
In the media
December 12, 2023

Navigating the micro and macro realms of biology through spatial omics and AI

Authors
No items found.
About Owkin

Owkin is the first end-to-end TechBio company on a mission to understand complex biology and derive new multimodal biomarkers through AI. We identify precision therapeutics, de-risk and accelerate clinical trials and develop diagnostics using AI trained on world-class patient data through privacy-enhancing federated technologies.

We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation in oncology, cardiovascular, immunity and inflammation. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research.

Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like Fidelity, GV and Bpifrance, among others.

Navigating the micro and macro realms of biology through spatial omics and AI

No items found.
No items found.
No items found.